We observed that 1/3 of the mice showed detectable NY-ESO-1 TCR-T cells on both day 7 and day 21 post-treatment (results not shown here), suggesting that OVV-01 can induce the generation of NY-ESO-1-specific T cells in tumor tissues. This evidence concerns the gene CTAG1B and neoplasm.